EPISODE · Jul 30, 2013 · 10 MIN
FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?
from Clinical Chemistry Podcast
The US Food and Drug Administration has long maintained its right to regulate LDTs; however until recently they've chosen to exercise discretion and have left this to the individual laboratories and other regulatory agencies. This is now in a state of change, and the FDA has stated that it would issue guidance on its oversight of Laboratory Developed Tests.
Embed this episode
NOW PLAYING
FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories?
0:00
10:57
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Clinical Chemistry Podcast?
This episode is 10 minutes long.
When was this Clinical Chemistry Podcast episode published?
This episode was published on July 30, 2013.
Can I download this Clinical Chemistry Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!